BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel) 2019;6:E21. [PMID: 30709019 DOI: 10.3390/medicines6010021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alavi M, Rai M. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria. Expert Rev Anti Infect Ther 2019;17:419-28. [PMID: 31046483 DOI: 10.1080/14787210.2019.1614914] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
2 Hazlett LD, Ekanayaka SA, McClellan SA, Francis R. Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies. Invest Ophthalmol Vis Sci 2019;60:2978-89. [PMID: 31311033 DOI: 10.1167/iovs.19-27200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
3 Cattoir V, Felden B. Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges. J Infect Dis 2019;220:350-60. [PMID: 30893436 DOI: 10.1093/infdis/jiz134] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]